drugset / Trial / NCT06563375
Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors
RandomizedSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and preliminary efficacy of NP-101 in patients with solid tumors.
Timeline
- Start
- 2025-03-05
- Primary completion
- 2028-09-01
- Completion
- 2030-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NP-101 | Traditional medicine (herbal / TCM) | — | Oral |